The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity.
about
Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptorNK cell function and receptor diversity in the context of HCV infectionThe evolution of natural killer cell receptorsEffects of Peptide on NK cell-mediated MHC I recognitionEvasion from NK cell-mediated immune responses by HIV-1Suppression of a Natural Killer Cell Response by Simian Immunodeficiency Virus PeptidesCrystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2The Structure and Stability of the Monomorphic HLA-G Are Influenced by the Nature of the Bound PeptideActivating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South AfricaCutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activationDifferential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptorsCanonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C.Recruitment of activation receptors at inhibitory NK cell immune synapsesNatural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).Matched sizes of activating and inhibitory receptor/ligand pairs are required for optimal signal integration by human natural killer cells.The virus-specific and allospecific cytotoxic T-lymphocyte response to lymphocytic choriomeningitis virus is modified in a subpopulation of CD8(+) T cells coexpressing the inhibitory major histocompatibility complex class I receptor Ly49G2KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motifPeptide antagonism as a mechanism for NK cell activation.Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptorsThe role of zinc in the binding of killer cell Ig-like receptors to class I MHC proteinsHIV-1 adaptation to NK-cell-mediated immune pressureHLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell functionUncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I moleculeA single amino acid change in inhibitory killer cell Ig-like receptor results in constitutive receptor self-association and phosphorylation.Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell functionHuman-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblastsHost genes important to HIV replication and evolution.Innate immune control of HIV.In silico characterization of immunogenic epitopes presented by HLA-Cw*0401Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis.A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cellsSelective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells.A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognitionStress signals activate natural killer cells.Putting the natural killer cell in its place.Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success.Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses.The Yin and Yang of HLA and KIR in human disease
P2860
Q24671977-F7B47E9F-3184-4F6F-944D-B4627E067C6DQ26781537-AD66BC53-C531-4DDF-B2E2-A12EB3D7E0B1Q26782592-48655547-A0EF-44F6-8B5A-0C768515CC40Q26822893-A8F89A0D-6FDB-480B-955B-4584EBD0A01AQ26864489-C4A9FF46-CE87-4D37-A6C8-0D36DB5DA8DDQ27317377-2C30FC16-BF10-4256-A4FF-CEF8AAF99104Q27617783-7A9F6050-6385-4537-9C62-5728E13A50AAQ27659367-CE6DAD75-6530-49F6-908A-1A1914F4D299Q27681802-D9BB849E-27C4-435B-887F-5EEB8C1A50A5Q28607344-59D7956C-8CF2-4145-99C3-D9F6E5A7C449Q28610728-3B7FB8A3-6C21-4985-BDB1-3D4EE9DFCF57Q28776435-19D10DE3-F1D4-495C-BD54-0C0D66A0A74FQ30252783-28B8BD1D-E579-4E70-885B-C7B2C7C20ABDQ33372126-50F888DC-C054-4EA6-AEA4-A91FC488FB46Q33672480-EF428EE2-CCEA-424A-8655-5E603A7B5715Q33778625-C95924CD-E42F-4718-94C6-087DD6C6B763Q33808966-3CEC26C9-F227-4437-9A48-0B8648D0751EQ33851496-1D6CC0C8-377D-4BDF-B1CB-D00B8E02E11FQ33933479-DA8A2146-CA25-485F-B90A-7C29CAF94CDBQ33947906-76604895-8447-4829-B654-3507FD892592Q34100457-FF0F5105-2562-430E-AD4E-4987CE07FE08Q34205851-646C0F2C-D3B4-4580-9E9B-18685B98CAA6Q34341384-14BF53BF-BE01-4982-A025-6317926EE2F3Q34482335-CEF2B1B2-C1FF-4207-B7B4-9B6E5BE0DF7AQ34810583-30EDF114-0944-4A5D-982B-6A49480B61E4Q35678598-1143EBEF-ECB9-4212-B014-816AA04CCFECQ35701077-BFA96FBE-02F1-4730-9290-28F824B6A7FCQ35788425-DBCF97F8-92C2-4887-92C1-4C6B14D9A54FQ35853016-44DA09C3-228E-4737-8F06-320277EC3FFDQ36065864-12E1D689-D99F-4673-BD30-4AA14BAB6FC4Q36088477-99908AF8-8CFA-4AB8-839A-1B2C23461610Q36183939-95CE4B40-876B-4DC4-A2AA-34D02B7E4BC8Q36229149-E5662FE0-5ED2-4ABD-988C-9657A93C0ED0Q36370648-3A1DE027-7C82-4A2C-8BD6-3EB2A3CB0ADDQ36371883-AB363C86-23CC-44A4-AB0E-FE9F4DE47A84Q36371909-65DEA9C8-D9E0-4889-8526-6F2479908ECDQ36372539-7F38D63C-9490-47E4-96B1-68BCCE7D4611Q36399286-2BEE6DF2-8B04-4BA0-AA53-5DB65F3DC88FQ36407362-1B62628F-27F4-425F-A007-6A2AE1734110Q36410540-A2A4F784-DBBC-470A-961C-0F90763D14AD
P2860
The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
The direct binding of a p58 ki ...... exhibits peptide selectivity.
@ast
The direct binding of a p58 ki ...... exhibits peptide selectivity.
@en
type
label
The direct binding of a p58 ki ...... exhibits peptide selectivity.
@ast
The direct binding of a p58 ki ...... exhibits peptide selectivity.
@en
prefLabel
The direct binding of a p58 ki ...... exhibits peptide selectivity.
@ast
The direct binding of a p58 ki ...... exhibits peptide selectivity.
@en
P2860
P356
P1476
The direct binding of a p58 ki ...... exhibits peptide selectivity.
@en
P2093
Rajagopalan S
P2860
P304
P356
10.1084/JEM.185.8.1523
P407
P577
1997-04-01T00:00:00Z